Autolus Ltd (NASDAQ:AUTL)

Autolus Ltd (NASDAQ:AUTL)

Share Price
$ 15.24
-0.47 (-2.99 %)
Market Cap
$685.52 m
Proactive Investors - Run By Investors For Investors

Autolus Ltd

Focused on the development of precisely targeted, controlled and highly active T cell therapies that are designed to offer cancer patients substantial benefits over existing standard of care.
Autolus is a leader in T cell programming technologies and believes its leadership will provide a competitive advantage as it looks to develop future generations of T cell therapies targeting both...

52-week High/Low: $53.14 / $14.63
Sector: Health Care, Equipment & Services
Market Cap: $685.52 m
col 3
col 4
col 5
col 6

Autolus Ltd Timeline

Market Reports Including AUTL


© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use